Item 9 Labs Corp. — Form D/A

Item 9 Labs Corp. of PHOENIX, AZ, a company, filed a Form D amendment with the SEC on 2021-02-26. The offering totals $13.0M, of which $12.1M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2021-02-26
• Form: D/A
• Accession: 0001554795-21-000056
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $13.0M
• Amount sold: $12.1M
• Remaining: $876K
• Minimum investment: $85K
• Investors: 122
• Date of first sale: 2020-11-13
• Security types: equity
• Revenue range: $5,000,001 - $25,000,000
• SEC file number: 021-384703

Issuer

• Name: Item 9 Labs Corp.
• CIK: 0001500123
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2010
• Address: 2727 NORTH 3RD STREET, PHOENIX, AZ, 85004
• Phone: 833-867-6337

Officers, directors & promoters (24)

Other filings by this issuer (6)

More

• CIK 1500123 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search